Approved Hospital Formulary
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

Benzarlizumab

Benzarlizumab
Drug Name Form Strength Notes
Fasenra SOLUTION, SUBCUTANEOUS 30 mg/mL (1 mL)


Additional Information:

Benzarlizumab (Fasenra) is non-formulary for inpatient use. Ordering limited to outpatient use in pulmonary clinic or infusion clinics and prescribing by pulmonologists or ANP only.


Last updated: Apr. 2, 2021







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.